BLCO vs CNC · rev $4.79B vs P/E 8.4, rev $163.07B
Bausch + Lomb Corp (BLCO) versus Centene Corp (CNC) — a side-by-side from cached financials, not a winner call.
Bausch + Lomb Corp (BLCO) is a medical instruments & supplies company listed on NYSE.
Centene Corp (CNC) is a healthcare plans company listed on US.
Latest reported BLCO revenue for 2024-12-31 was $4.79B. Net income was -$305.0M. Revenue was up 15.6% from 2023-12-31 to 2024-12-31. BLCO currently screens at market cap $5.38B.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
BLCO currently screens at market cap $5.38B. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Not investment advice. Open the BLCO and CNC stock pages for the full models.
Not investment advice.